Incruse Ellipta is a medicine used to relieve the symptoms of chronic obstructive pulmonary disease (COPD) in adults. COPD is a long-term disease in which the airways and air sacs inside the lungs become damaged or blocked, leading to difficulty breathing. Incruse Ellipta is used for maintenance (regular) treatment. Incruse Ellipta contains the active substance umeclidinium bromide.
Therapeutic Indication
### Therapeutic indication Indicated as a maintenance bronchodilator treatment to relieve symptoms in adult patients with chronic obstructive pulmonary disease (COPD).
Therapeutic Area (MeSH)
ATC Code
R03BB07
ATC Item
umeclidinium bromide
Pharmacotherapeutic Group
Drugs for obstructive airway diseases
Active Substance (Summary)
INN / Common Names
| Substance | CAS | Monograph |
|---|---|---|
| umeclidinium bromide | N/A | GSK-573719 |
EMA Name
Incruse Ellipta (previously Incruse)
Medicine Name
Incruse Ellipta (previously Incruse)
Aliases
N/A
